Proanthocyanidin A1 ameliorated chemotherapy-induced thrombocytopenia by activating JAK2-STAT3 signaling, enhancing JAK2 thermal stability and upregulating JAK2 expression [90]. Here, JAK2 is linked to Thrombocytopenia.